{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:51:42Z","timestamp":1761630702573},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.dld.2014.10.013","type":"journal-article","created":{"date-parts":[[2014,11,15]],"date-time":"2014-11-15T19:33:05Z","timestamp":1416079985000},"page":"170-173","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["How thiopurines are used for the treatment of inflammatory bowel diseases: An Italian survey"],"prefix":"10.1016","volume":"47","author":[{"given":"Simone","family":"Saibeni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianmichele","family":"Meucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Papi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2014.10.013_bib0005","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0140-6736(69)90325-0","article-title":"Azathioprine for Crohn's disease","volume":"20","author":"Brooke","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2014.10.013_bib0010","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2036.2006.02980.x","article-title":"Review article: thiopurines in inflammatory bowel disease","volume":"24","author":"Derijks","year":"2006","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2014.10.013_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2036.2005.02520.x","article-title":"Review article: practical management of inflammatory bowel disease patients taking immunomodulators","volume":"22","author":"Siegel","year":"2005","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2014.10.013_bib0020","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00228-008-0478-6","article-title":"Clinical pharmacology and pharmacogenetics of thiopurines","volume":"64","author":"Sahasranaman","year":"2008","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.dld.2014.10.013_bib0025","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1572-0241.2008.01848.x","article-title":"Thiopurine induced myelotoxicity in patients with inflammatory bowel disease: a review","volume":"103","author":"Gisbert","year":"2008","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.013_bib0030","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00007691-199608000-00003","article-title":"Individualizing therapy with 6-mercaptopurine and 6-thioguanine related to the thiopurine methyltransferase genetic polymorphism","volume":"18","author":"Lennard","year":"1996","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.dld.2014.10.013_bib0035","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1046\/j.1365-2036.2002.01353.x","article-title":"Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease","volume":"16","author":"Ansari","year":"2002","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2014.10.013_bib0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.MIB.0000206544.05661.9f","article-title":"5-Aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine","volume":"12","author":"Hande","year":"2006","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2014.10.013_bib0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cgh.2006.11.020","article-title":"Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine","volume":"5","author":"Sparrow","year":"2007","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2014.10.013_bib0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/00365520150218084","article-title":"Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease","volume":"36","author":"Belaiche","year":"2001","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.013_bib0055","first-page":"568","article-title":"Monitoring of thiopurine methyltransferase and thiopurine metabolites to optimize azathioprine therapy in inflammatory bowel disease","volume":"29","author":"Gisbert","year":"2006","journal-title":"Gastroenterologia y Hepatologia"},{"key":"10.1016\/j.dld.2014.10.013_bib0060","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/apt.12511","article-title":"A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis","volume":"38","author":"Kennedy","year":"2013","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2014.10.013_bib0065","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2036.2008.03915.x","article-title":"Systematic review: does concurrent therapy with 5-ASA and immunomodulators in inflammatory bowel disease improve outcomes?","volume":"29","author":"Andrews","year":"2009","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2014.10.013_bib0070","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1365-2036.2008.03788.x","article-title":"Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease","volume":"28","author":"Ansari","year":"2008","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2014.10.013_bib0075","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.dld.2008.03.016","article-title":"The use of thiopurines for the treatment of inflammatory bowel diseases in clinical practice","volume":"40","author":"Saibeni","year":"2008","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2014.10.013_bib0080","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/ibd.21662","article-title":"Use of thiopurine testing in the management of inflammatory bowel diseases in clinical practice: a worldwide survey of experts","volume":"17","author":"Roblin","year":"2011","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2014.10.013_bib0085","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ibd.20345","article-title":"How are azathioprine and 6-mercaptopurine dosed by gastroenterologists. Results of a survey of clinical practice","volume":"14","author":"Yip","year":"2008","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2014.10.013_bib0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2036.2011.04905.x","article-title":"Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease","volume":"35","author":"Chouchana","year":"2012","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2014.10.013_bib0095","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cgh.2012.01.018","article-title":"Initiating azathioprine for Crohn's disease","volume":"10","author":"Levesque","year":"2012","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2014.10.013_bib0100","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1053\/j.gastro.2013.10.047","article-title":"American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-\u03b1 biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease","volume":"145","author":"Terdiman","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.013_bib0105","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.crohns.2012.09.002","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis. Part 2: Current management","volume":"6","author":"Dignass","year":"2012","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1016\/j.dld.2014.10.013_bib0110","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/ibd.21494","article-title":"Optimizing thiopurine therapy in inflammatory bowel disease","volume":"17","author":"Chevaux","year":"2011","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2014.10.013_bib0115","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ibd.20750","article-title":"Co-prescribing azathiopurine or 6-mercaptopurine and 5-aminosalicylate compounds in ulcerative colitis","volume":"15","author":"Mayberry","year":"2009","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2014.10.013_bib0120","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1053\/j.gastro.2006.01.048","article-title":"American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease","volume":"130","author":"Lichtenstein","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.013_bib0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.crohns.2011.09.009","article-title":"Physician perspectives on unresolved issues in the use of conventional therapy in Crohn's disease: Results from an international survey and discussion programme","volume":"6","author":"Ferrante","year":"2012","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1016\/j.dld.2014.10.013_bib0130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/jcph.2","article-title":"Recent advances using immunomodulators for inflammatory bowel disease","volume":"53","author":"Nielsen","year":"2013","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.dld.2014.10.013_bib0135","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/apt.12075","article-title":"Myelosuppression monitoring after immunomodulator initiation in veterans with inflammatory bowel disease: a national practice audit","volume":"36","author":"Hou","year":"2012","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2014.10.013_bib0140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ibd.21048","article-title":"World Gastroenterology Organization practice guidelines for the diagnosis and management of IBD in 2010","volume":"16","author":"Bernstein","year":"2010","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2014.10.013_bib0145","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.2010.224154","article-title":"Guidelines for the management of inflammatory bowel disease in adults","volume":"60","author":"Mowat","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.dld.2014.10.013_bib0150","article-title":"Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease (Review)","volume":"Issue 4","author":"Prefontaine","year":"2009","journal-title":"Cochrane Database"},{"key":"10.1016\/j.dld.2014.10.013_bib0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crohns.2009.12.002","article-title":"The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management","volume":"4","author":"Dignass","year":"2010","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1016\/j.dld.2014.10.013_bib0160","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1572-0241.2008.01848.x","article-title":"Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review","volume":"103","author":"Gisbert","year":"2008","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.013_bib0165","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1053\/j.gastro.2013.09.035","article-title":"Lymphoma the b\u00eate noire of the long-term use of thiopurines in adult and elderly patients with inflammatory bowel disease","volume":"145","author":"Beaugerie","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.013_bib0170","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1053\/j.gastro.2011.07.039","article-title":"Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease","volume":"141","author":"Singh","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.013_bib0175","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1053\/j.gastro.2010.07.039","article-title":"Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system","volume":"139","author":"Velayos","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.013_bib0180","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ibd.20857","article-title":"Survey of gastroenterologists\u2019 awareness and implementation of AGA guidelines on osteoporosis in inflammatory bowel disease patients: are the guidelines being used and what are the barriers to their use","volume":"15","author":"Wagnon","year":"2009","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2014.10.013_bib0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.gcb.2008.07.012","article-title":"TNF antagonists in the treatment of inflammatory bowel disease: results of a survey of gastroenterologists in the French region of Lorraine","volume":"33","author":"Peyrin-Biroulet","year":"2009","journal-title":"Gastroenterologie Clinique et Biologique"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865814007580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865814007580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T12:38:22Z","timestamp":1566045502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865814007580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1590865814007580"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2014.10.013","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How thiopurines are used for the treatment of inflammatory bowel diseases: An Italian survey","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2014.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}